Early detection of oral potentially malignant disorders (OPMD) and oral squamous cell carcinoma (OSCC) can improve patient prognosis. Biopsy remains the reference standard for diagnosing OPMDs and OSCC, but advances in diagnostic technologies and living guideline methodologies have created a need for updated guidance on early cancer detection. Developed in collaboration with the Center for Integrative Global Oral Health at the University of Pennsylvania School of Dental Medicine (Penn Dental Medicine), the first three parts of a multi-part series exploring cancer detection methods provides recommendations on when cytology, vital staining, and light-based adjuncts may be appropriate.
Part four of the series will examine salivary tests, to be published summer 2026.
For questions or comments about the living guideline, please contact livingguidelineprogram@ada.org.
Please note: the infographic below may take a moment to load.